Met Life Investment Management, LLC Cv Rx, Inc. Transaction History

Met Life Investment Management, LLC

  • $17.1 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024
SELL
$6.49 - $19.2 $21,728 - $64,281
-3,348 Reduced 53.24%
2,941 $35,000
Q1 2024

May 14, 2024
BUY
$17.99 - $30.49 $113,139 - $191,751
6,289 New
6,289 $114,000
Q3 2023

May 09, 2024
BUY
$13.56 - $18.47 $85,278 - $116,157
6,289 New
6,289 $95,000
Q2 2023

Apr 29, 2024
BUY
$8.57 - $15.44 $53,896 - $97,102
6,289 New
6,289 $97,000
Q2 2023

Aug 10, 2023
BUY
$8.57 - $15.44 $53,896 - $97,102
6,289 New
6,289 $97,000

Others Institutions Holding CVRX

# of Institutions
84
Shares Held
14.4M
Call Options Held
56.3K
Put Options Held
41.8K
View Full List

About CVRx, Inc.

CVRX Quotes by TradingView
  • Ticker CVRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 20,576,200
  • Market Cap $292M
  • Description
  • CVRx, Inc., a commercial-stage medical device company, focuses on developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases. It offers Barostim, a neuromodulation device indicated to improve symptoms for patients with heart failure (HF) with reduced ejection fraction or systolic HF. The co...
More about CVRX
Track This Portfolio

Track Met Life Investment Management, LLC Portfolio

Follow Met Life Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Met Life Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Met Life Investment Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email